Review Article

Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence

Table 1

Statistically significant variants from meta-analysis, false-positive report probabilities (FPRPs), and cumulative epidemiological evidence.

GeneVariantAllelesEthnicityMAF†StudiesNumber evaluationRisk of meta-analysisPQAmount of evidenceReplicationProtection from biasReason for bias exemptionVenice criteria grade§FPRP values at prior probability of 0.05 and OR of 1.5Cumulative epidemiological evidence
Sample size (case/control)Genetic modelsEffect modelOR (95% CI)valueI (%)N‡minorGradeGradePegger

POU5F1Brs6983267G > TOverall0.471030673 (7504/23169)AllelicF1.129 (1.086 − 1.174)≤0.0128.10.1929188ABCa0.25NoABC≤0.01Moderate
927428 (7018/20410)DominantF1.175 (1.107 − 1.247)≤0.010.00.4820223AAA0.33NoAAA≤0.01Strong
927428 (7018/20410)RecessiveF1.158 (1.091 − 1.228)≤0.0127.60.196725ABA0.28NoABA≤0.01Strong
miR-146ars2910164G > COverall0.321216737 (4857/11880)DominantR1.144 (1.003 − 1.304)≤0.0157.0≤0.018639ACCa0.89NoACC0.46Weak
FOXE1rs71369530>14-Ala vs. ≤14-AlaCaucasian0.2441271 (576/695)AllelicR1.836 (1.353 − 2.492)≤0.0164.50.04757BCA0.27NoBCA0.02Moderate
FOXE1rs907580C > TCaucasian0.2636884 (497/6387)AllelicR1.593 (1.184 − 2.145)≤0.0167.60.053733ACA0.80NoACA0.11Weak

NKX2-1rs944289C > TOverall0.551765182 (9467/55715)AllelicF1.304 (1.255 − 1.355)≤0.0145.50.0272278ABA0.40NoABA≤0.01Strong
1016277 (5187/11090)DominantF1.609 (1.465 − 1.767)≤0.0126.30.2012706ABA0.24NoABA≤0.01Strong
1016277 (5187/11090)RecessiveF1.414 (1.301 − 1.536)≤0.0140.50.095073ABA0.14NoABA≤0.01Strong

FOXE1rs965513G > AOverall0.341861943 (8167/53776)AllelicR1.703 (1.575 − 1.842)≤0.0166.7≤0.0143701ACA0.13NoACA≤0.01Moderate
914348 (3680/10668)DominantR1.694 (1.429 − 2.010)≤0.0168.4≤0.017542ACA0.17NoACA≤0.01Moderate
914348 (3680/10668)RecessiveF1.954 (1.729 − 2.208)≤0.0146.40.061599ABCd0.02NoABC≤0.01Moderate
DIRC3rs966423T > COverall0.5059604 (4953/4651)AllelicF1.227 (1.153 − 1.306)≤0.010.00.449931AAA0.13NoAAA≤0.01Strong
FOXE1rs1443434T > GCaucasian0.3949627 (2453/7174)AllelicR1.392 (1.084 − 1.787)≤0.0178.7≤0.017800ACA0.54NoACA0.20Weak

FOXE1rs1867277G > ACaucasian0.391221820 (5654/16166)AllelicF1.503 (1.426 − 1.583)≤0.0143.70.0518169ABA0.47NoABA≤0.01Strong
610702 (2958/7744)DominantR1.702 (1.352 − 2.143)≤0.0165.4≤0.016892ACA0.21NoACA≤0.01Moderate
610702 (2958/7744)RecessiveF1.703 (1.498 − 1.937)≤0.0144.40.111809ABA0.20NoABA≤0.01Strong
FOXE1rs2439302C > GOverall0.3549265 (3146/6119)AllelicF1.325 (1.240 − 1.415)≤0.0125.60.267409ABA0.42NoABA≤0.01Strong
FOXE1rs30215269T > CCaucasian0.3936997 (684/6313)AllelicR1.634 (1.254 − 2.127)≤0.0162.00.075555ACA0.99NoACA0.97Weak

MTHFR C677Trs1801133C > TOverall0.3086267 (2902/3365)AllelicR1.418 (1.114 − 1.806)≤0.0171.4≤0.014276ACA0.39NoACA0.12Weak
97454 (3447/4007)DominantR1.383 (1.081 − 1.769)≤0.0169.0≤0.014337ACA0.31NoACA0.20Weak
86267 (2902/3365)RecessiveF1.258 (1.081 − 1.464)≤0.0143.10.09843BBA0.95NoBBA0.06Moderate

RET A45Ars1800858G > AOverall0.3184620 (1867/2753)AllelicF0.898 (0.818 − 0.987)0.0318.90.282885AACab0.24NoAAC0.33Weak
74462 (1809/2653)DominantF0.867 (0.764 − 0.984)0.0311.00.352358AACb0.55NoAAC0.34Weak

RET G691Srs1799939G > AOverall0.21126643 (2853/3790)AllelicR1.352 (1.171 − 1.561)≤0.0153.8≤0.012934ACA0.12NoACA≤0.01Moderate
126643 (2853/3790)DominantR1.386 (1.155 − 1.664)≤0.0155.6≤0.012475ACA0.63NoACA≤0.01Moderate
126643 (2853/3790)RecessiveR1.535 (1.224 − 1.924)≤0.010.00.90459BAA0.29NoBAA≤0.01Strong

RET S836Srs1800862C > TCaucasian0.04146654 (2701/3953)AllelicF1.129 (1.008 − 1.409)0.0421.80.22637BBCab0.74NoBBC0.88Weak
95791 (2250/3541)DominantF1.283 (1.058 − 1.557)≤0.0136.60.13500BBCd≤0.01NoBBC0.19Weak
RET S904Srs1800863C > GOverall0.1963073 (1178/1895)RecessiveF1.578 (1.090 − 2.286)0.020.00.75124BAA0.48NoBAA0.43Weak

TERTrs2736100T > GAsian0.39510104 (5052/5052)AllelicF1.430 (1.352 − 1.512)≤0.0122.60.278802ABA0.49NoABA≤0.01Strong
510104 (5052/5052)DominantF1.535 (1.411 − 1.668)≤0.0115.50.326768AAA0.95NoAAA≤0.01Strong
510104 (5052/5052)RecessiveF1.666 (1.509 − 1.839)≤0.010.00.722034AAA0.64NoAAA≤0.01Strong

XRCC3 A17893Grs1799794A > GOverall0.2942477 (1106/1371)AllelicR1.275 (1.008 − 1.613)0.0471.20.021519ACCc0.33NoACC0.47Weak
42477 (1106/1371)DominantR1.321 (1.023 − 1.705)0.0355.40.081184ACCc0.73NoACC0.43Weak
42477 (1106/1371)RecessiveF1.383 (1.092 − 1.750)≤0.0129.80.23335BBCc0.74NoBBC0.15Weak

XRCC3rs861539C > TOverall0.24115978 (2413/3565)AllelicR1.363 (1.193 − 1.559)≤0.0153.90.023142ACCd0.03NoACC≤0.01Moderate
115978 (2413/3565)DominantR1.357 (1.135 − 1.622)≤0.0156.9≤0.012570ACA0.35NoACA0.62Weak
115978 (2413/3565)RecessiveF1.709 (1.428 − 2.046)≤0.0119.60.26572BACd≤0.01NoBAC≤0.01Moderate

F: meta-analysis was performed under the fixed-effects model. R: meta-analysis was performed under the random-effects model. Overall: two or more ethnicities were reported in the study. †Frequency of minor allele in controls. ‡Number of test allele or genotype. §Venice criteria grades are amount of evidence, replication of the association, and protection from bias. Cumulative epidemiological evidence as graded by the combination of results from the Venice criteria and FPRP. aThe grade of C is given because the OR value is between 0.87 and 1.15, and the association is not replicated by GWAS or GWAS meta-analysis. bThe grade of C is given for no significant association existed by excluding the first published study. cThe grade of C is given for no significant association existed by excluding studies deviated from the HWE in the controls. dThe grade of C is given for significant publication bias (Pegger ≤0.05)